Morphogenesis, Inc. Is Testing Cancer Vaccine
Scientists at UF startup Morphogenesis, Inc., a clinical-stage immunotherapy company headquartered in Tampa, call the “therapeutic vaccine” a simple and safe technology that could help people who already have cancer fight it off. Six patients with stage three and stage four melanoma started the trial in November 2018. Morphogenesis, Inc., is working with specialists at Moffitt […]
Morphogenesis, Inc. Is Developing a Cell and Gene Therapy Focusing on a Cancer Vaccine Immunotherapy That Uses the Body’s Own Immune System to Kill Solid Tumors
Dr. Patricia Lawman, CEO and co-founder of UF startup Morphogenesis, Inc., a clinical-stage immunotherapy company headquartered in Tampa, talks about the company, their projects – current and future – and the challenges she and her team have to face while developing cell and gene therapy technologies. “We are currently focusing on our cancer vaccine. This […]
Morphogenesis, Inc. Moves Forward With Development of Cancer Vaccine
UF startup Morphogenesis, Inc., a clinical-stage immunotherapy company headquartered in Tampa, has been working on the research for nearly 20 years and has already completed phase one of its clinical trial on the treatment which the company says will be directly inserted into cancerous tumors through several methods. “It actually triggers the early response and […]
Coolest Office Spaces: Morphogenesis Creates Interactive Spaces for Big Minds
UF startup Morphogenesis is a clinical-stage immunotherapy company headquartered in Tampa. The company’s principal focus is a platform of cancer vaccines that utilize both cell and gene therapies to stimulate the immune system to recognize and combat tumor cells. Since the company is involved in research, development and manufacturing, a unique, creative environment is critical. […]
Morphogenesis and Lacerta Named as Finalists for SEBIO Awards (SEBIO)
Two UF startups who have incubated at UF Innovate | Sid Martin Biotech have been named as finalists for the SEBIO awards. Sid Martin alum Morphogenesis is a finalist in Initial Venture Funding; Sid Martin resident client Lacerta Therapeutics is a finalist in the Strategic Investment category. Over the past two decades, the Southeast has […]
Morphogenesis Focused on Cancer Treatment Launches First Human Clinical Study (Tampa Bay Business Journal)
UF startup Morphogenesis Inc. is launching its first human clinical study for treatment for skin cancer. It’s an important benchmark for the Tampa company, a UF Innovate | Sid Martin Biotech alumnus, which raised $16 million earlier this year in a Series A investment round led by entrepreneur and philanthropist Dr. Kiran Patel. The Phase […]
Morphogenesis to Begin Clinical Trials on Promising Cancer Therapy (WLRN)
A UF startup based in Tampa has received approval to start clinical trials on a new form of gene therapy to treat cancerous tumors. Morphogenesis, Inc. will begin the trials on six patients with an aggressive form of skin cancer at Moffitt Cancer Center this summer. The therapeutic vaccine is injected into a cancerous tumor […]
Morphogenesis, Inc. Raises $16M to Advance into Human Clinical Trials (BioFlorida)
UF startup Morphogenesis, Inc., a Tampa, FL-based immunotherapy company closed a $16 million Series A investment round led by Dr. Kiran Patel and KP Biotech Group, a company managed by Dr. Kiran Patel. With the completion of the Series A Round, Dr. Kiran Patel was elected Chairman of the Board of Morphogenesis. Newly elected […]